Wednesday, September 16, 2009

Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 - ESMO 34 Congress

Key Denosumab and Vectibix(R) (Panitumumab) Data to be Presented: Amgen announced it will present detailed data from four Phase 3 studies as well as other data at the ECCO 15 - ESMO 34 European Multidisciplinary Congress, September 20 - 24, 2009 in Berlin, Germany. 

Read the rest of this entry

Posted in Press Releases, Product News

Wednesday, September 16, 2009

Amgen Scholars Europe Programme Convenes Undergraduates From 15 Countries for Innovative Science Research

Symposium Offers Unique Opportunity to Meet Peers and Leading Scientists; Discuss Hands-On Summer Research Projects

Read the rest of this entry

Posted in Press Releases

Monday, September 14, 2009

Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference

THOUSAND OAKS, Calif. – Sept. 14 – Amgen (Nasdaq: AMGN) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 17, 2009, in London, beginning at 9:50 a.m. Greenwich Mean Time. Amgen executives will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, http://www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases

Sunday, September 13, 2009

Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis

Poor Adherence Can Lead to Higher Fracture Risk, More Frequent Hospital Admissions and Higher Medical Costs

DENVER – Sept. 13 – Amgen Inc. (Nasdaq: AMGN) today announced the presentation of data highlighting the links between medication satisfaction, adherence to therapy and fracture risk reduction among women with postmenopausal osteoporosis. The data were presented at the 31st annual meeting of the American Society for Bone Mineral Research (ASBMR).

Read the rest of this entry

Posted in Press Releases

Friday, September 11, 2009

Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference

THOUSAND OAKS, Calif. – Sept. 11 – Amgen (Nasdaq: AMGN) will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Monday, Sept. 14, 2009, at the Grand Hyatt hotel in New York City, beginning at 12:00 p.m. Eastern Time. Amgen Chairman and CEO Kevin Sharer will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, http://www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases